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Abstract
Background: In Uganda, control of intestinal schistosomiasis with preventive chemotherapy is typically focused towards
treatment of school-aged children; the needs of younger children are presently being investigated as in lakeshore
communities very young children can be infected. In the context of future epidemiological monitoring, we sought to
compare the detection thresholds of available diagnostic tools for Schistosoma mansoni and estimate a likely age of first
infection for these children.
Methods and Findings: A total of 242 infants and preschool children (134 boys and 108 girls, mean age 2.9 years, minimum
5 months and maximum 5 years) were examined from Bugoigo, a well-known disease endemic village on Lake Albert.
Schistosome antigens in urine, eggs in stool and host antibodies to eggs were inspected to reveal a general prevalence of
47.5% (CI95 41.1–54.0%), as ascertained by a positive criterion from at least one diagnostic method. Although children as
young as 6 months old could be found infected, the average age of infected children was between 3J–3L years, when
diagnostic techniques became broadly congruent.
Conclusion: Whilst different assays have particular (dis)advantages, direct detection of eggs in stool was least sensitive
having a temporal lag behind antigen and antibody methods. Setting precisely a general age of first infection is problematic
but if present Ugandan policies continue, a large proportion of infected children could wait up to 3–4 years before receiving
first medication. To better tailor treatment needs for this younger ageclass, we suggest that the circulating cathodic antigen
urine dipstick method to be used as an epidemiological indicator.
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Introduction
Throughout the last decade several large-scale preventive
chemotherapy campaigns, waged against neglected tropical
diseases, have progressively scaled up operations to reach
nationwide coverage levels in Uganda [1,2]. For control of
intestinal schistosomiasis, as caused by Schistosoma mansoni infection,
an active monitoring and surveillance programme, set within the
national control programme (NCP), has provided important
disease-specific information, assessing the impact of treatment
upon the recipient population, as well as, re-alignment of original
control objectives first set forth in 2003 [3,4].
Following WHO guidelines, mass-drug administration of
praziquantel (PZQ) is typically focused towards treatment of
school-aged children ($6 years) and adults who reside within
disease endemic regions [5,6]. PZQ is provided free of charge by
the NCP and analysis of school and(or) community treatment
registers has shown that several million people have received at
least one annual treatment of PZQ within the last five years [1,7].
Although this represents a considerable achievement, targeted
epidemiological surveys have revealed that coverage is incomplete
as in certain areas, e.g. shoreline environments of Lakes Victoria
and Albert, large numbers of preschool-aged children (#5 years)
and infants (#1 years) are infected with S. mansoni and have been
largely overlooked by the treatment campaign [8,9,10].
To ensure that this unfortunate health inequality does not
persist the treatment needs of younger children are being assessed
and we have recently called for formal inclusion of these young
children within the Ugandan NCP [11]. It can be safely assumed,
for example, that mass-treatment initiatives are vital in most in
shoreline villages where infections can be common. Given the
geographical focality of schistosomiasis and itinerancy of lakeshore
communities, however, an important future challenge for the NCP
is collection of sufficient disease-specific information to better tailor
local drug needs and set parameters for subsequent programme
monitoring [12,13]. Attention will therefore focus upon those
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sections of villages where young children are frequently bathed in
freshly drawn lake water or are within range of regular ambulation
to the lake margins.
Owing to the unique natural history and developmental biology
of schistosomes within the mammalian host [14], accurate
identification of infected cases is challenging [15], even more so
in the younger child where the founding worm population has only
recently established and begun to mature. Before female worms
develop their full egg-laying capacity, sporadic deposition of eggs
may take place with a proportion of these being voided into the
bowel lumen and ejected in faeces whilst the remainder become
trapped within the host’s tissues [16]. Interacting with this are also
the beginnings of the child’s innate and adaptive immune responses
to excretory-secretory products of the worms themselves, as well as
these responses being primed or modulated by maternally induced
effects, for example, during pregnancy and(or) breastfeeding
[17,18,19,20]. It is also of particular note that the child’s immune
system is in a maturing flux of recognition between self- and non-
self epitopes [21] and the efficacy of PZQ, which is poor against
immature worms of S. mansoni [22], is only starting to be explored in
this ageclass [11]. From a general diagnostic perspective as existing
tools are sub-optimal, improvement of methods and techniques for
detection of intestinal schistosomiasis continues [15] but in the
context of the younger child, it is not yet clear which of the present
methods, or combinations thereof, is either most appropriate or
applicable for routine use within the NCP.
We therefore report on a field-based study which attempted to
determine the age of first infection in very young children with
available techniques and also estimate, as accurately as possible,
the general prevalence of intestinal schistosomiasis within this
ageclass from a typical lakeshore community. The performance of
methods that detect schistosome - antigens in urine, antibodies to
egg antigens in serum and eggs in stool - was compared. For ease
of comparison, our methods are subsequently referred to as: an
antigen detection method (ADM), an indirect egg detection
method (IEDM) and a direct egg detection method (DEDM),
respectively.
Materials and Methods
This field study was carried out in April 2009 in Bugoigo on
Lake Albert (GPS co-ordinates, N 01u 549.4810, E 31u 249.5970), a
fishing village impoverished both in terms of sanitation and
hygiene that has been the location of several previous research/
control studies on intestinal schistosomiasis [23,24,25,26]. Preva-
lence of infection within local school-aged children has been
continuously high (.50%) despite annual chemotherapy [27] and
infections in infants and preschool children were first formally
recorded in July 2007 [11].
Study location and participants
Owing to itinerancy, the exact number of inhabitants in
Bugoigo is not precisely known but is likely in the region of several
thousand. The village contains up to three thousand traditional
hut dwellings which stretch 3–4 km along the lakeshore and up to
1–2 km inland. Sanitation and hygiene in this village is minimal
with few potable water sources and insufficient pit latrines.
Household water is typically drawn directly from the lake at
specific collection points and then taken back to each homestead in
plastic jerry cans for subsequent domestic use. These lakeshore
margins, like elsewhere on Lake Albert, provide conducive aquatic
habitats for Biomphalaria spp., the intermediate snail hosts of S.
mansoni, and can be found throughout the year, although infected
snails vary in numbers seasonally [28,29].
The immediate and longer-term objectives of this study were
explained to the local community mobiliser who identified a total
of 134 mothers that were willing to participate, bringing up to two
of their infants/preschool children (#5 years of age), and attend
the two-day clinic commencing on the following day. After
obtaining written informed consent from each mother on her own
behalf and on behalf of her child(ren), urine, stool and fingerprick
blood samples were obtained from all participants on the first day
of the clinic. Mothers were then asked a suite of detailed questions
recording their demography and water contact behaviours (the
questionnaire is available upon request to the corresponding
author).
After receipt of the second-day stool (and urine sample), all
participants, regardless of their infection status, were treated for
schistosomiasis and soil-transmitted helminthiasis with PZQ
(40 mg/kg) (CIPLA, Mumbai, UK) and 400 mg albendazole
(GSK, Uxbridge, UK) under medical supervision in conditions
typical of mass-drug administration [30]. For smaller children, a
chewable albendazole half-tablet (200 mg) was given and PZQ
tablets were first crushed in orange juice before being adminis-
trated by spoon-feeding by their mother under supervision. The
diagnostic findings for schistosomiasis here are reported for the
children only.
Schistosome antigens in urine (ADM)
Each child’s urine sample was visually inspected for macro-
haematuria/turbidity and a random sample was tested for micro-
haematuria with Hemastix (Bayer, UK) to exclude the possibility
of urinary schistosomiasis or other active urinary tract infections. A
50 ml aliquot was then tested for the presence of schistosome
circulating cathodic antigen (CCA) using a commercially available
lateral flow immuno-chromatographic urine dipstick (Rapid
Medical Diagnostics, Pretoria, RSA) originally developed in
Holland [31]. On a subset of 90 children, urine-CCA tests were
performed in duplicate to assess variation between dipsticks.
To facilitate better recording of the visual intensity of the CCA
reaction band within the test zone, results were visually graded
against a reference chart for: trace, single (+), double (++) and
triple (+++) positive reactions [32]. When creating binomial
variables to depict infection status according to CCA, two
variations were taken into account: the first considering trace
results as negative infection status and the second considering trace
Author Summary
In sub-Saharan Africa, intestinal schistosomiasis is a
debilitating disease caused by a worm infection. To arrest
disease progression, de-worming medications are given
out, often en masse, to school-aged children. In Uganda,
however, much younger children can be infected, and in
lakeshore communities both infants and pre-school
children can already show signs and symptoms of
intestinal schistosomiasis. To change de-worming practic-
es, further information on the occurrence of infections in
these younger is needed for evidence-based decision
making. Our study applied current methods of disease
diagnosis to better define the ‘age of first infection’ and
estimate general infection prevalence within a disease-
endemic village. Up to 50% of young children were clearly
shown to have schistosomiasis and could likely wait up to
3–4 years before obtaining first treatment if present de-
worming policies are not changed. In the context of
identifying future treatment needs, we propose that
antigen detection methods are most suitable.
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results as positive infection status. The urine CCA reagent strip is
referred to as an ADM (antigen detection method) from now on.
Antibodies to soluble egg antigens (IEDM)
A commercially available ELISA kit (IVD Inc.; Carlsbad, USA)
was used to test for host antibodies (IgG/M) to soluble egg
antigens (SEA) according to manufacturer’s instructions. Approx-
imately 75 ml of finger-prick blood was taken from each child and
serum was harvested, then diluted 1:40 with specimen dilution
buffer before loading a total of 100 ml into each ELISA microwell
[11]. Positive and negative control sera were included on each
batch of testing. Upon completion, each ELISA plate was placed
on a white card and the colour within each microwell (ranging
from colourless to yellow) was recorded by visual inspection.
Positive reactions were classified either as trace (faint yellow),
single (+, light yellow), double (++, yellow) or triple (+++, dark
yellow) upon visual comparison with the control sera. The SEA-
ELISA is referred to as an IEDM (indirect egg detection method)
from now on.
Direct egg-detection methods in stool (DEDM)
Three parasitological methods Kato-Katz, percoll and FLO-
TAC, henceforth referred to as direct egg detection methods
(DEDMs), were attempted on each stool specimen to visualise
eggs. However, owing to the differing amounts of stool required
for each technique, it was not always possible to assemble a
complete data set for every child with each of these three methods.
Duplicate Kato-Katz (K-K) thick smears (41.7mg) were made
from first and second day stool samples (N= 242 children) [33].
The four faecal smears were each examined under the microscope
at x100, schistosome eggs were counted and later expressed as eggs
per gram (epg) of faeces. Infection intensity was classified as light
(1–100 epg), medium (101–400 epg) and heavy (.400 epg)
infections according to WHO guidelines [5]. The methodology of
Eberl [34] using sedimentation of schistosome eggs by centrifu-
gation through a solution of percoll (Percoll 77237 (1.130 g/ml),
Fluka, Sigma-Aldrich Chemie GmbH, Switzerland) was also
implemented on-site to visualize eggs (N= 96 children on first day
stool). The egg-floatation procedure known as FLOTAC [35] was
performed off-site back in Kampala on a formalin-fixed stool
specimen archive (N= 191 children taken from the second day
stool) whereby schistosome eggs are collected by floatation
centrifugation through a solution of zinc sulphate at specific
gravity of 1.35.
Data handling and statistical analyses
Data were collected from each individual using pro-forma data
sheets, which were then transferred into electronic format using
Microsoft Excel. The data thus collated were analysed using MS
Excel and R statistical package version 2.8.0 [36]. For prevalence
data and diagnostic parameters, 95% confidence intervals (CI95)
were estimated using the exact method [37]. Prevalence
comparisons were performed using (one-tailed) Fisher’s exact
modification of the 262 chi-squared test [38]. For infection
intensity values, the arithmetic mean of positive cases was chosen
as the measure of central tendency. Data from the FLOTAC and
percoll methods were analysed by combining with K-K results and
revising the diagnostic criterion so individuals were considered
positive if an egg was detected by at least one DEDM.
The diagnostic performances of the ADM (including and
excluding trace reactions as a positive diagnosis) and IEDM were
tested qualitatively as a rapid diagnostic for intestinal schistoso-
miasis, considering DEDMs as the ‘gold-standard’. Additionally, a
third ‘gold standard’ was created using data from the ADM
(including and excluding trace reactions as positive diagnoses)
against which to test IEDM data (N= 242). Diagnostic sensitivity,
specificity, positive predictive value (PPV) and negative predictive
value (NPV) were calculated according to the different ‘gold
standards’ [38]. The diagnostic powers of ADM and IEDM were
calculated using all individuals, and then segregated by sex or age
(#3 years of age versus .3 years of age). P-values ,0.05 were
considered indicative of statistical significance [38].
Ethical approvals
Approvals for this study were granted by the Ugandan Council
for Science and Technology and the London School of Hygiene
and Tropical Medicine (application numbers 06.45 and 5538.09).
After sensitisation of the local community to the study objectives,
verbal assent was first requested from each mother which was then
formalised upon written informed consent (for her and behalf of
her child), as either a thumbprint or signature on data recording
sheet. This was witnessed by a Vector Control Division Officer.
PZQ treatment (40 mg/kg) was offered to all study participants
irrespective of their infection status.
Results
A complete data set for the ADM, IEDM and Kato-Katz
examinations was obtained from a total of 242 children (134 boys:
108 girls, mean age 2.9 years, minimum 5 months and maximum
5 years). However, owing to insufficient amounts of stool available,
the FLOTAC and percoll methods could only be performed on
191 and 96 children, with the former and latter finding 4 and 2
additional egg-positive cases, respectively.
Estimating infection prevalence
The prevalence of intestinal schistosomiasis estimated by each
diagnostic method, and combinations thereof, is shown in Table 1
and Fig. 1. Prevalence inferred by DEDM, ADM (including trace
reactions as positive diagnoses) and IEDM (considering traces as
negatives) were: 24.4%, 42.6% and 45.9%. Of the children who
were egg-positive by K-K, three quarters had ‘light’ intensity
infections. Girls were equally as likely as boys to be diagnosed
positively for intestinal schistosomiasis by ADM (Odds Ratio (OR)
= 1.06, p= 0.90) and DEDM examinations (OR=0.72, p = 0.29).
Children under the age of three, however, were less likely to be
positive by ADM (OR=0.51, p = 0.016) or by DEDM (OR=
0.26, p,0.0001) than their older counterparts. The prevalence of
positives by IEDM was 45.9%. General prevalence inferred by
pooling DEDM and IEDM was 47.7%, with no further change in
prevalence when ADM was then added, see Fig. 1. There was no
discordance between duplicate CCA testing for negative or
positive classifications (data not shown).
Ages of becoming first positive
The age of first positive (AFP) for each method is presented in
Table 1. For DEDM, the youngest child with eggs in stool was 9
months old, with medium and heavy infections found at 3 and 5
years of age, respectively. For ADM, trace reactions, single, double
and triple positives were found in an ascending series of 6 months,
9 months, 11 months and 2 years of age, respectively. For IEDM,
trace reactions began at 5 months of age while single, double and
triple positive reactions were found in children as young as 6
months, 1 year and 9 months old, respectively. All tests concur on
a mean age of first infection within the third year of life. ADM
detected infections slightly ahead of I/DEDMs (3.2 years v. 3.4
years v. 3.7 years, respectively). The order of this temporal series is
Diagnosis of Schistosomiasis in Young Children
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largely concordant with an absolute minimum age of becoming
first positive.
Cross-tabulations of diagnostic scores
In the absence of a genuine ‘gold standard’ where the infection
status of each child is precisely known, it is necessary to explore
relationships between diagnostic scores and infection intensities
empirically, and to cross-tabulate diagnostic permutations by investi-
gation. There was negligible variation in diagnostic performance of
all protocols tested when classifying the data according to sex and age
(data not shown) and general trends were reported from now on.
Plotting the relationship between ADM and DEDM revealed
some immediate trends, Fig. 2. Whilst there were children positive
for ADM who were egg-negative, as the epg increases there was a
corresponding increase in the proportion of positive ADM tests
and once medium/heavy intensity infections were reached, all
ADM tests were clearly positives, see Fig. 2A. Plotting the faecal
epg of each child against the intensity of the corresponding ADM
test further revealed this positive association, see Fig. 2B.
Considering the relationship between IEDM and DEDM
revealed similar trends, see Fig. 3. Despite some children being
positive for IEDM while being egg-negative, as the faecal epg
increases there was a corresponding increase in the IEDM
reaction strength, with all medium/heavy intensity infections
diagnosed as clear strong positives (Fig. 3A & B).
The relationship between ADM and IDEM was less clear-cut.
Children who were ADM negative or trace had a median negative
(or trace) IEDM reaction, but the proportionate increase of ADM
positives with rising IEDM designations of positive (+) or strong
positives (++/+++) was not as great as that seen with DEDM. For
example, nearly 40% of children who were IEDM strong positive
elicited a negative ADM reaction, Fig. 4A. As the intensity of the
ADM result stepped up towards double and triple positive
reactions, this typically corresponded better with increasing IEDM
classifications, Fig. 4B.
Using available data it was possible to conduct an exploration of
diagnostic performances of the ADM and IEDM versus DEDM
and against each other (Table 2). First, considering an ADM trace
reaction to be an infection negative and comparing with positive
diagnosis by at least one of the DEDMs, the ADM had a sensitivity
of 59.3%, specificity of 95.6%, PPV of 81.4% and NPV of 87.9%.
When considering an ADM trace reaction to be a positive
infection, and comparing to diagnosis by at least one of the
DEDMs, ADM had a sensitivity of 81.4%, specificity of 69.9%,
PPV of 46.6% and NPV of 92.1%.
The IEDM when compared to diagnosis by DEDM, demon-
strated a sensitivity of 93.2%, specificity of 69.4%, PPV of 49.5%
and NPV of 96.9%. For details on the performance of the ADM or
IEDM compared to diagnosis by all DEDMs (using a subset of the
data), and for CI95 around each value, see Table 2.
Discussion
With limited access to safe water sources, and high levels of local
transmission of S. mansoni, conditions in Bugoigo are particularly
Figure 1. Barchart of the prevalence of intestinal schistosomi-
asis by each diagnostic technique (as well as pooling
techniques, DEDM* representing results obtained from Kato-
Katz, Percoll and FLOTAC methods) for the examined children.
Note that the DEDMs under estimate infection prevalence and the
addition of ADM to DEDMs/IEDM data did not further increase
cumulative infection prevalence.
doi:10.1371/journal.pntd.0000938.g001
Table 1. Prevalence and intensity of intestinal schistosomiasis and age of first positive by each diagnostic method.
No. tested Prevalence (%) CI95 (%) Mean epg (of positives) AFP
$
DEDM (Two-sample double-smear Kato-Katz) 242 21.9 16.9–27.6 86.4 9 months
KK light intensity (,100 epg) 16.9 12.4–22.3 9 months
KK medium intensity (100–399 epg) 4.5 2.3–8.0 3 years
KK heavy intensity (.399 epg) 0.4 0.0–2.3 5 years
ADM (CCA incl. trace) 242 42.6 36.3–49.1 NA 6 months
+ reaction 17.8 13.2–23.2 9 months
++ reaction 11.6 7.8–16.3 11 months
+++ reaction 1.7 0.5–4.2 2 years
IEDM (SEA-ELISA) 242 45.9 39.5–52.4 NA 6 months
+ reaction 15.3 11.0–20.5 6 months
++ reaction 19.4 14.6–25.0 1 year
+++ reaction 11.2 7.5–15.8 9 months
DEDMs (all*) 242 24.4 19.1–30.3 NA NA
IEDM+DEDM +ADM 242 47.5 41.1–54.0 NA NA
$Age of first positive.
*Note not all 242 children were examined with percoll and FLOTAC (see methodology).
doi:10.1371/journal.pntd.0000938.t001
Diagnosis of Schistosomiasis in Young Children
www.plosntds.org 4 January 2011 | Volume 5 | Issue 1 | e938
conducive for young children to acquire S. mansoni infections, and
from a very early age. Approximately half of our children had
intestinal schistosomiasis. As might be expected, regardless of
techniques used, there was an obvious positive association between
increasing diagnostic patency of infection with increasing age of
the child. Presumably this was resultant from a progressive
temporal accumulation of antigens, eggs and antibodies. Congru-
ence between diagnostic methods became most apparent in
children between 3J–3L years of age, broadly consistent with
the overall mean age of infected children within our sample.
Prevalence of intestinal schistosomiasis in children under 3 years of
age, however, was 35.5% (CI95 27.9–43.8%) and other studies
have also revealed that schistosomiasis in very young children can
be common [9,11,39].
While egg excretions of these children were of ‘light’ intensity,
such infected children will not normally receive praziquantel
treatment until they have either entered primary school or if the
NCP now formally extends its treatment remit to include this
ageclass. Thus an infected child could therefore wait up to 3–4
years before receiving first treatment, and with this may have
already entered a more ‘chronic’ stage of disease [40,41,42,43].
For example, earlier clinical and ultrasound studies in Uganda in
Figure 2. Comparisons of ADM and DEDM. Figure 2A Rectangular bar chart representing egg infection intensity classifications (as calculated
by Kato-Katz) versus reaction intensity of the ADM (visual strength of the CCA urine dipstick test band). Figure 2B Boxplot of the egg faecal epg
against ADM reaction intensity shows a positive increasing association.
doi:10.1371/journal.pntd.0000938.g002
Figure 3. Comparisons of IEDM and DEDM. Figure 3A Rectangular bar chart representing egg infection intensity classifications (as calculated
by Kato-Katz) versus reaction intensity of the IEDM (visual strength of the SEA-ELISA test well). Figure 3B Boxplot of the egg faecal epg against IEDM
reaction intensity shows a positive increasing association.
doi:10.1371/journal.pntd.0000938.g003
Diagnosis of Schistosomiasis in Young Children
www.plosntds.org 5 January 2011 | Volume 5 | Issue 1 | e938
children aged 6 and above, have shown significant hepatospleno-
megaly (i.e. putative morbidity from intestinal schistosomiasis), and
while they have not yet developed pipe-stem liver fibrosis, up to
15% can have diffusely echogenic livers with pocketed foci, typical
of image pattern B (‘the starry sky’ classification) [3,27]. Without
medication, it is likely that these preschool children will progress
towards ‘moderate’ infection intensities before they become of
school age. This might better explain the observations of Balen
et al. that many adolescent Ugandan children have surprisingly
severe intestinal schistosomiasis [44]. Although it is not yet proven
that infection in very early childhood leads to heightened
morbidity in later childhood and adolescence, this scenario
appears plausible.
From animal models, it is known that only a fraction of
penetrating cercariae successfully migrate to, and later mature in,
the hepatic portal system. After adult worms reach full fecundity,
schistosome eggs can be found in stool around 6 weeks after
cercarial exposure and it is commonly held that females of S.
mansoni produce up to 100–300 eggs per day, although many fail to
be voided into the faeces [16]. Given the insensitivity of DEDMs
in stool [34], it is not surprising that false negatives are inferred
and the low egg-detection threshold(s) likely contribute to the
longer apparent lag of 7–8 months between infection and egg-
patency apparent between experimental schistosomiasis and the
situation in the field. Moreover, it should be noted that the
relationship between excreted eggs in stool and worm burdens is
not always straightforward [45] and that infected laboratory
animals are typically exposed with a single substantive dosing of
cercariae. By contrast, and in this natural setting, exposure and
infection is likely a more gradual process, i.e. the so-called trickle
infection dynamic [46], and our children are at least two orders of
magnitude greater in body size than most animal models.
Figure 4. Comparisons of ADM and IEDM. Figure 4A Rectangular bar chart representing ADM intensity classifications (visual strength of the
CCA urine dipstick test band) versus reaction intensity of the IEDM (visual strength of the SEA-ELISA test well). Figure 4B Boxplot of the IEDM
reaction intensity against ADM shows a positive increasing association but the relationship is less clear-cut than that shown in Figures 2B & 3B.
doi:10.1371/journal.pntd.0000938.g004
Table 2. Comparison of diagnostic scores by ADM and IEDM using DEDM (all) as ‘gold standard’.
Diagnostic test Diagnostic target N Sensitivity Specificity PPV NPV
(%,CI 95) (%,CI 95) (%,CI 95) (%,CI 95)
ADM (excl. trace) DEDM 242 59.3 95.6 81.4 87.9
(45.8–71.9) (91.6–98.1) (66.6–91.6) (82.6–92.1)
ADM (incl. trace) DEDM 242 81.4 69.9 46.6 92.1
(69.1–96.3) (62.7–76.5 (36.7–56.7) (86.3–96.0)
IEDM DEDM 242 93.2 69.4 49.5 96.9
(83.5–98.1) (62.2–76.0) (40.0–59.2) (92.4–99.2)
ADM (excl. trace) 242 86 62.8 33.3 95.4
(72.1–94.7) (56.0–69.5) (24.7–42.9) (90.3–98.3)
ADM (incl. trace) 242 60.2 64.7 55.9 68.7
(50.1–69.7) (56.2–72.7) (46.1–65.3) (60.0–76.5)
doi:10.1371/journal.pntd.0000938.t002
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An age of first infection?
While some children were patently infected during the first year
of life, others were not. Thus a sub-set of children exists with
increased infection risk factors which we explain by the following
synopsis. As children are born throughout the year, in a largely
asynchronous fashion, whilst their initial age of first exposure to
unsafe water might be broadly similar (i.e. within first few months
of life as mothers begin to bathe them in jerry-can collected water
or in the lake directly) their accumulated infection risk will not be
equivalent owing the seasonality of local transmission factors and
their particular timeframe of exposure within it contingent upon
their mother’s infant bathing and domestic water drawing
practices [11].
Estimating this accumulated risk of infection reliably over the
seasonal time frame of potential exposure is problematic as day-to-
day variations within water collection times, its storage and actual
domestic use (within each household) introduce many stochastic
processes. Estimating cumulative infection risk is therefore easily
confounded but an ad hoc investigation of infection risk associated
with jerry-can collected water in June 2009, however, has
confirmed that sentinel laboratory-bred mice could become
infected to freshly drawn water [28]. Seasonal patterns, which
operate in umbrella fashion over and above these specific-exposure
patterns, no doubt effect this asynchronous age of first infection.
Thus there will be no ‘absolute age’ of first infection but rather a
‘range of ages’ depending upon these intricate covariates of
exposure. Only after a child has passed through sufficient
‘windows of exposure’, their probability of infection rises to an
eventual certainty, after which, it is incumbent on the diagnostic
tools to capture their parasitological status as accurately as
possible.
Comparison of diagnostic scores
From first appearances the ADM looks to best capture and
identify infections in early stage, especially when we consider trace
results as putative infection positives. A contentious issue in the use
of the CCA reagent strip has been the interpretation of the exact
diagnosis of this ‘trace’ result which can be confounded by non-
specific inflammatory factors or breast-feeding [32,47]. Interpre-
tation of ‘trace’ is more contentious when surveying children
under three years of age, where worm burdens are presumably
lower than what might be expected in their school-aged
counterparts. Interestingly, the percentage change in prevalence
estimated according to the CCA reagent strip when excluding and
including trace results as a positive diagnosis is significantly larger
in the very young children (#3 years of age) –10.1% v. 36.2%
(+358%) – than in those aged four and five years of age –30.1% v.
52.7% (+175%) which is fitting with our understanding of
increasing worm burdens through time. Thus we postulate that
using ‘trace’ as positive firmly points towards a future use of the
urine CCA-dipstick as an early indicator of infections which are as
yet to become egg- or antibody-patent. It is particularly notable
that the prevalence based on the ADM, when considering trace as
positive, is very close to that of IEDM (Fig. 1), yet the diagnostic
performance with it was not particularly congruent (see Fig. 3 and
Table 2) so we still have an incomplete understanding of this
infection progression. The dynamics of other ADM have been
explored elsewhere in the context of recently acquired infection
but not in very young children [48].
The ADM showed very promising diagnostic performance and
robust field performance with high sensitivity and NPV scores
(83.9% and 85.3%, respectively) when we considered trace results
as a positive diagnoses and very high specificity and PPV scores
(95.5% and 90.5%, respectively) when we considered trace results
as negative diagnoses. This bimodal use of the test criteria could be
advantageous from a control perspective. For instance, if a
confident estimate of the suspected occurrence of infections within
a population is needed, one should consider trace results as
positives. On the other hand, to monitor the prevalence of ‘actual’
infection, or rather more easily identify those who do not, one
should consider trace results as negatives. The former would be
important if treatments were to be given out en masse as triggered
by exceeding an aggregated local prevalence threshold while the
latter would be important if treatment were to be withheld in an
individual patient setting on the basis of test and treat.
Towards promotion of safe water
With the gradual rise of infection prevalence in older children
(over and above our asynchronous infection hypothesis), this trend
must represent the spread of several risk factors, rather incipiently,
across our cohort. Aggregation of infections in schistosomiasis is
well-known [49] but it would be interesting to establish why
approximately half of our study cohort had no evidence of
infection despite living within the same village. As we were
insufficiently aware of the exact locations of sampled households
within the village, this could simply represent a cryptic spatial
micro-patterning (i.e. these children who live slightly further away
from the lake have less contact with viable cercariae) so we are
now undertaking fine scale mapping of these individual households
with GPS units. If, however, other causal factors could be
identified and, perhaps more importantly, were these amenable to
manipulation, it could lead to future infection mitigation measures.
Presently, within the NCP there are no health education
materials targeted towards these mothers and their young
children. More importantly and in terms of policy realignment
of the NCP, a useful formal recommendation would be to initiate
cross-sectorial activities with water and sanitation NGOs to
improve immediately the domestic water quality at Bugoigo and
elsewhere along the Lake Albert shoreline. Rather than focusing
upon expensive infrastructure development, it could be achieved
by introduction of simple water storage or modification measures.
For example, as schistosome cercariae are an ephemeral larval
stage, freshly drawn water can be rendered harmless for
schistosomiasis by simple resting for 24 hrs, by crude filtration
or by introduction of mild disinfectants [16]. Thus without
initiating a better dialogue with these women of children bearing
age through better public health education, mothers will remain
sadly ignorant of the risks that making use of this unsafe water has
for themselves and that of the future health of their child [11]. In
this dialogue, the NCP should be receptive to explore which
infection mitigation measures are best feasible and, by this token,
help to provide safe water for domestic use which is well-received,
implementable and effective.
Epidemiological indicators and treatment needs
It is evident that infants and preschool children in Bugoigo, and
other similar lakeshore villages of Uganda [12], are living in need
of treatment. However, addressing how these children could be
best identified is not yet clear, as are epidemiological parameters
which should be collected for estimating treatment needs and also
impact assessment. For example, should mass-treatment of all
infants/preschool children take place when a sub-sample of an
equivalent age range has been proven to be infected, or should
treatment be allocated based at an individual level using the result
of a diagnostic test in a ‘test and treat’ setting?
It is outside the remit of this present paper to make a cost-
effectiveness calculation but a clear drawback of the IEDM
method is that, whilst initially useful to establish if a child is
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infected (and there is no evidence in these data to suggest a passive
maternal transfer of antibodies has been confounding), monitoring
this parameter after treatment will be largely uninformative owing
to residual antibody titres remaining after infection has putatively
cleared. Thus IEDM is only useful at baseline but as an initial
estimate of infection prevalence could be powerfully applied in
identification and selection of villages, or sentinel locations, to first
define the extent of the problem at intervention baseline. This of
course assumes the majority of examined children can mount an
antibody response and is not confounded by high levels of
immune-suppression, by HIV for example, which is likely high in
these fishing villages.
In contrast, both ADM and DEDMs have the potential ability
to better track the dynamics of worm populations after treatment
[22,34] but the insensitivity of DEDMs is of particular concern.
Put simply, numerous adult worms may reside within the host but
are yet not depositing sufficient eggs to be visualised in stool on the
day of sampling. Thus through lack of alternatives a pragmatic
way forward would be to focus upon more widespread application
of the ADM. The advantages of the ADM have been discussed
elsewhere in the context of programmatic monitoring [14] but the
future challenge will be for the NCP to meet the financial costs of
using these rapid diagnostic tests in scale-up of operations. This is
particularly true if these are to be used in a ‘test and treat’ setting
when large numbers of tests would be utilized [14]. Given the low
price of PZQ treatment, to maintain an affordable diagnosis versus
treatment differential, a rational strategy would be to examine a
sub-set of children and if local prevalence exceeded a given
threshold, mass-treatment is advised. Such a strategy is presently
within the resources available to the NCP but best sample sizes
and prevalence thresholds remain to be determined.
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